期刊文献+

苦参碱对肺纤维化大鼠肺组织HYP与HGF表达的影响 被引量:3

Effect of Matrine on Bleomycin-induced Pulmonary Fibrosis in Rats and the Expression of HGF and HYP in Lung Tissue
原文传递
导出
摘要 目的探讨HYP与HGF在肺纤维化中的作用及不同浓度苦参碱对博莱霉素诱导的肺纤维化大鼠肺组织中HGF及HYP表达的影响。方法健康雄性SD大鼠90只,随机分为6组。应用气管内给予博莱霉素(5 mg/kg)制作肺纤维化动物模型。各组动物大鼠在造模7、14、28 d时分三次取材。检测肺组织HYP的含量。用RT-PCR,Westernblot检测各组肺组织中HGF mRNA及蛋白的表达。结果在正常肺组织中,HGF及HYP均有表达。肺纤维化时,肺组织中HYP的含量较正常组织明显上升(P<0.01),而HGF明显减少(P<0.01)。与模型组相比,高、中剂量苦参碱与泼尼松,均能减轻肺间质纤维化程度,以苦参碱高剂量组和泼尼松组明显(P<0.01)。苦参碱低剂量组与模型组相比,其肺组织HGF、HYP的表达差异无统计学意义(P>0.05)。结论苦参碱抑制肺纤维化的机制之一可通过增高HGF的活性实现,这种作用有一定的剂量依赖性。 Objective To explore the role of hydroxyproline(HYP) and hepatocyte growth factor(HGF) in pulmonary fibrosis,and to discuss the effect of different concentrations of matrine on bleomycin-induced pulmonary fibrosis in rats and the expression of HGF and HYP in lung tissue.Methods Ninety healthy male SD rats were randomly divided into six groups.All the rats were given intratracheal bleomycin(5 mg/kg) for producing pulmonary fibrosis models.Five rats in each group were sacrificed 7,14,and 28 days after intratracheal instillation.The content of HYP in lung tissue was detected.The mRNA of HGF was detected by in situ hybridization,and the level of HGF protein was further measured by Western blot analysis.Results In the normal lung tissue,HGF and HYP were expressed.Compared with normal lung tissue,the content of HYP in pulmonary fibrosis was significantly increased(P0.01),while HGF was reduced significantly(P0.01).Compared with model group,the high-dose and medium-dose matrine and prednisone could decrease the degree of pulmonary fibrosis,but the high-dose matrine and prednisone decreased it significantly(P0.01).No statistically significant difference was found in the expression of HYP and HGF in lung tissue between low-dose matrine group and model group(P0.05).Conclusions One of the mechanisms for inhibiting pulmonary fibrosis could be achieved by increasing the activity of HGF through matrine,and this effect has a dose-dependent manner.
出处 《实用预防医学》 CAS 2011年第6期998-1001,共4页 Practical Preventive Medicine
关键词 苦参碱 肺纤维化 肝细胞生长因子 羟脯氨酸 Matrine Pulmonary fibrosis Hepatocyte growth factor Hydroxyproline
  • 相关文献

参考文献12

  • 1蔡颖.肺纤维化的药物治疗进展[J].世界临床药物,2008,29(1):17-19. 被引量:3
  • 2Miachael C, Surrenti C, Milani S. Transforming growth factors O1 and beta2 are differentially expressed infibrotic liver disease[J]. Bone Joint- Surge, 1991, (73) : 1418. 被引量:1
  • 3Toshikazu Nakarnura, Katsuhiko Nawa and Akira Ichihara. Partial pu- rification and characterization of hepatocyte growth factor from serum of hepatectomized rats[J]. Biochemical and Biophysical Research Commu- nications, 1984, (3) .. 1450 - 1459. 被引量:1
  • 4Toshikazu Nakarnura, Tsutomu Nishizawa, Mitchio Hagiya, et al. Molecular cloning and expression of human hepatocyte growth factor [J]. Letters To Nature,1989, (23) :440 442. 被引量:1
  • 5洪阁,刘培勋.槐属植物生物碱化学成分及药理作用研究进展[J].中草药,2005,36(5):783-788. 被引量:31
  • 6江苏新医学院.中药大辞典[M].上海:上海科学技术出版社,2005.1 489. 被引量:65
  • 7Ramadori G, Neubauer K, Odenthal M, et al. The gene of hepatocyte growth factor is expressed in fat-storing cells of rat liver and is down regulaved during cell growth and by transforming growth factor 13 [J ] Biochem Biophys Res Commun, 1992,183(2) :739 - 742. 被引量:1
  • 8Nishino T, Kaise N, Sindo Y, et al. Promyelocytic leukemia cell line, HL-60, produces human hepatocyte growth factor [ J ]. Biochem Bio, phys Res Commun, 1991,181 ( 1 ) : 323 - 330. 被引量:1
  • 9Yoshinaga Y, Fujita S, Gotoh M, et al. Human lung cancer cell line producing hepatocyte growth factor/scatter factor [ J ]. Jpn J Cancer Res, 1992,83(12) :1257 - 1261. 被引量:1
  • 10Wolf IlK, Zarnegar R, Michalopoulos G, et al. Localization of hepa- tocyte growth factor in human and rat tissues: an immunohistochemieal study[J]. Hepatoloty, 1991, 14(3):488-494. 被引量:1

二级参考文献34

  • 1王秀坤,李家实.苦参碱等槐属六种生物碱对GAB_A受体的作用[J].北京中医药大学学报,2000,23(S1):42-43. 被引量:16
  • 2王秀坤,李家实,闫玉凝.槐属羽扇豆类生物碱及其药理作用研究概况[J].国外医药(植物药分册),1996,11(1):9-14. 被引量:11
  • 3Lurton JM,Trejo T,Narayanan AS,et al.Pirfenidone inhibits the stimulatory effects of profibrotic cytokines on human lung fibroblasts in vitro[].American Journal of Respiratory and Critical Care Medicine.1996 被引量:1
  • 4Raghu G,Johnson WC,Lockhart D,et al.Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone:results of a prospective,open-label PhaseⅡstudy[].American Journal of Respiratory and Critical Care Medicine.1999 被引量:1
  • 5Simone NL,Soule BP,Gerber L,et al.Oral Pirfenidone in patients with chronic fibrosis resulting from radiotherapy:a pilot study[].Radiotherapy and Oncology.2007 被引量:1
  • 6Azuma A,Nukiwa T,Tsuboi E,et al.Double-blind,placebo- controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis[].American Journal of Respiratory and Critical Care Medicine.2005 被引量:1
  • 7Aono Y,Nishioka Y,Inayama M,et al.Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice[].The Journal of Experimental Medicine.2005 被引量:1
  • 8Vuorinen K,Gao F,Oury TD,et al.Imatinib mesylate inhibits fibrogenesis in asbestos-induced interstitial pneumonia[].Experimental Lung Research.2007 被引量:1
  • 9Tzortzaki EG,Antoniou KM,Zervou MI,et al.Effects of antifibrotic agents on TGF-betal,CTGF and IFN-gamma expression in patients with idiopathic pulmonary fibrosis[].Respiratory Medicine.2007 被引量:1
  • 10Bajwa EK,Ayas NT,Schulzer M,et al.Interferon-gamma1b therapy in idiopathic pulmonary fibrosis:a metaanalysis[].Chest.2005 被引量:1

共引文献95

同被引文献76

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部